![Brian Cathers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Cathers
No open positions remaining
Profile
Brian Cathers worked as an Executive Director-Protein Homeostasis at Celgene Corp.
from 2015 to 2019.
He also worked as a Chief Scientific Officer at Global Blood Therapeutics, Inc. Dr. Cathers completed his undergraduate degree at Emporia State University and his graduate and doctorate degrees at the University of Kansas.
Former positions of Brian Cathers
| Companies | Position | End |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 2019-01-31 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Brian Cathers
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
76
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Emporia State University
 Emporia State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kansas
 University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
- Stock Market
- Insiders
- Brian Cathers
